Back to Resource Center
National Judicial Opioid Task Force
Regional Judicial Opioid Task Force
FROM THE TASK FORCE
Prenatal Substance Exposure: Improving Outcomes for Women and Infants
Questions or comments?
Screening and Assessment
Screening and Assessment Tools (American Society of Addiction Medicine-ASAM)
Treatment and recovery support near you (2019, Addiction Resource Center)
Screening and Assessment of Co-occurring Disorders in the Justice System (SAMHSA)
TIP 31: Screening and Assessing Adolescents for Substance Use Disorders (6/2012, SAMHSA): Guidelines in screening and assessing teens for substance use conditions.
Addiction Severity Index, Fifth Edition (Thomas McLellan, Ph.D.; Deni Carise, Ph.D.; Thomas H. Coyne, MSW; T. Ron Jackson, MSW)
Forms (Texas Christian University Institute of Behavioral Research)
GAIN Instruments (Global Appraisal of Individual Needs-GAIN))
TCU Drug Screen 5 (2017, TCU Institute of Behavioral Research)
TCU Drug Screen 5 - Opioid Supplement (9/2017, TCU Institute of Behavioral Research)
Opioid Risk Tool (National Institute on Drug Abuse)
Medication Assisted Treatment
Treatment of Opioid Use Disorder (9/2018, NJOTF): Discusses key issues surrounding medication assisted treatment (MAT), the evidence that underlies treatment types for opioid use disorder, best practices, and legal implications.
Medication-Assisted Treatment (MAT) (4/2019, SAMHSA)
Treatment Approaches for Drug Addiction (1/2019, National Institute on Drug Abuse)
Medications to Treat Opioid Use Disorder: How is opioid use disorder treated in the criminal justice system? (6/2018, National Institute on Drug Abuse): Useful to start a discussion on the current state of treatment.
Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions (2018, The American Journal of Drug and Alcohol Abuse)
Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder (6/2017, Journal of Adolescent Health)
Medication-Assisted Treatment of Adolescents with Opioid Use Disorders (9/2016, Pediatrics, American Academy of Pediatrics Committee on Substance Use and Prevention)
Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition) (1/2018, National Institute on Drug Abuse)
MAT Overview (SAMHSA-HRSA Center for Integrated Health Solutions)
Behavioral Health Treatment Services Locator (SAMHSA)
The Case for Medication-Assisted Treatment: MAT can help people with opioid use disorders, but few have access (1/2017, The Pew Charitable Trusts)
Medication-Assisted Treatment Improves Outcomes for Patients With Opioid Use Disorder (11/2016, The Pew Charitable Trusts)
Naloxone in Correctional Facilities for the Prevention of Opioid Overdose Deaths (4/2015, National Commission on Correctional Health Care)
Medication Assisted Treatment Studies
Drug Trials Snapshot: LUCEMYRA (5/2018, U.S. Food and Drug Administration)
Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone. (2/2018, Nunes EV, et al.)
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial. (1/2018, Lee JD, et al.)
Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. (4/2016, Hser YI, et al.)
Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment Study. (5/2015, Weiss RD, et al.)
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. (1/2014, Hser YI, et al.)
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. (12/2011, Weiss RD, et al.)
Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. (4/2011, Krupitsky E, et al.)
Treatment of Substance Use Disorder (SUD)
The ASAM Criteria (American Society of Addiction Medicine)
Patient Resources (American Society of Addiction Medicine):
Dynamic patient resource guide to addiction.
Finding Quality Treatment for Substance Use Disorders (4/2018, Substance Abuse and Mental Health Services Administration - SAMHSA)
Treatment Approaches for Drug Addiction (1/2018, National Institute on Drug Abuse)
Rx Pain Medications Know the Options, Get the Facts (11/2017, SAMHSA): Patient education fact sheet focusing on alternative pain management methods.
National Center for Trauma-Informed Care and Alternatives to Seclusion and Restraint (NCTIC) (9/2017, SAMHSA)
Treatment: Brief Description (6/2014, National Institute on Drug Abuse)
Program Profile: Interim Methadone Maintenance (IM) (6/2011, National Institute of Justice)
Program Profile: Methadone Maintenance Treatment (6/2011, National Institute of Justice)
Program Profile: Prize-Based Incentive Contingency Management for Substance Abusers (6/2011, National Institute of Justice)
Brief Interventions and Brief Therapies for Substance Abuse (1999, SAMHSA): Brief intervention and therapy techniques for the treatment of alcohol and drug misuse.
Medication Assisted Treatment of Opioid Use Disorder (OUD)
Naloxone Use in the Courthouse – A Judicial Bench Card (4/2019, NJOTF): Describes the signs of overdose, what to do if one occurs, how naloxone can be used to reverse the toxic effects of an overdose, and suggestions for a naloxone policy.
Overdose Reversal Toolkit (Addiction Policy Forum)
Medications to Treat Opioid Use Disorder (6/2018, National Institute on Drug Abuse)
Opioid Overdose Prevention Toolkit (6/2018, SAMHSA): Useful document, especially for taskforces.
Opioid Overdose Reversal with Naloxone (Narcan, Evzio) (4/2018, National Institute on Drug Abuse): Useful as a quick primer on naloxone for anyone who has not heard of it.
TIP 63: Medications for Opioid Use Disorder – Full Document (Including Executive Summary and Parts 1-5) (2/2018, SAMHSA)
Medication-Assisted Treatment for Opioid Use Disorders in Drug Courts (8/2016, National Drug Court Institute)
Advisory: Sublingual and Transmucosal Buprenorphine for Opioid Use Disorder: Review and Update (3/2016, SAMHSA)
Medication-Assisted Treatment of Opioid Use Disorder Pocket Guide (3/2016, SAMHSA)
The Facts about Buprenorphine for Treatment of Opioid Addiction (8/2015, SAMHSA)
The ASAM National Practice Guide for the Use of Medications in the Treatment of Addiction Involving Opioid Use (6/2015, American Society of Addiction Medicine)
Federal Guidelines for Opioid Treatment Programs (3/2015, SAMHSA)
Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide (12/2014, SAMHSA)
Medication-Assisted Treatment in Drug Courts: Recommended Strategies (2015, Legal Action Center)
Adult Drug Courts and Medication Assisted Treatment for Opioid Dependence (9/2014, SAMHSA)
Program Profile: Buprenorphine Maintenance Treatment (6/2011, National Institute of Justice)
Medication Assisted Treatment for Opioid Addiction in Opioid Treatment Programs: A Treatment Improvement Protocol TIP 43 (2005, SAMHSA)
Recovery Support Services
Treatment and recovery support near you (2019, Addiction Resource Center)
Discover the rewards of treating patients with Opioid Use Disorders (Providers Clinical Support System): Dynamic website to inform and educate medical professionals.
Building Recovery: State Policy Guide for Supporting Recovery Housing (2018, The National Council for Behavioral Health)
Decisions in Recovery: Treatment for Opioid Use Disorders (12/2016, SAMHSA)